Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
View ORCID ProfileCara E. Brook, View ORCID ProfileGraham R. Northrup, View ORCID ProfileAlexander J. Ehrenberg, the IGI SARS-CoV-2 Testing Consortium, View ORCID ProfileJennifer A. Doudna, View ORCID ProfileMike Boots
doi: https://doi.org/10.1101/2020.11.12.20230870
Cara E. Brook
1Department of Integrative Biology, University of California, Berkeley
2Department of Ecology and Evolution, University of Chicago
Graham R. Northrup
3Center for Computational Biology, College of Engineering, University of California, Berkeley
Alexander J. Ehrenberg
1Department of Integrative Biology, University of California, Berkeley
4Innovative Genomics Institute, University of California, Berkeley
5Helen Wills Neuroscience Institute, University of California, Berkeley
6Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco
4Innovative Genomics Institute, University of California, Berkeley
Jennifer A. Doudna
4Innovative Genomics Institute, University of California, Berkeley
7Department of Molecular and Cell Biology, University of California, Berkeley
8College of Chemistry, University of California, Berkeley
9J. David Gladstone Institutes, San Francisco, CA
10Howard Hughes Medical Institute, University of California, Berkeley
Mike Boots
1Department of Integrative Biology, University of California, Berkeley
11Department of Biosciences, University of Exeter, Penryn, UK
Data Availability
All code and corresponding data are made available in the article itself and in the cited open-access Github repository.
Posted October 27, 2021.
Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
Cara E. Brook, Graham R. Northrup, Alexander J. Ehrenberg, the IGI SARS-CoV-2 Testing Consortium, Jennifer A. Doudna, Mike Boots
medRxiv 2020.11.12.20230870; doi: https://doi.org/10.1101/2020.11.12.20230870
Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment
Cara E. Brook, Graham R. Northrup, Alexander J. Ehrenberg, the IGI SARS-CoV-2 Testing Consortium, Jennifer A. Doudna, Mike Boots
medRxiv 2020.11.12.20230870; doi: https://doi.org/10.1101/2020.11.12.20230870
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)